Funding for this research was provided by:
Icahn School of Medicine at Mount Sinai
Arnhold Institute for Global Health
Teva Pharmaceutical Industries
Received: 29 April 2021
Accepted: 23 November 2021
First Online: 22 December 2021
: The IRB at the Icahn School of Medicine at Mount Sinai reviewed this study protocol and determined it did not meet the federal regulatory definition for human subjects research, as per 45 CFR 46.102 (f). This determination by the IRB took into account ethical considerations of the study and included waiving the need for consent.
: Not applicable.
: SK serves as a consultant for Resolve to Save Lives and has led partnerships on chronic conditions supported by the Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and Teva Pharmaceuticals.